Abstract-Africa is a continent characterized by marked ethnic, sociodemographic, and economic diversity, with profound changes in many regions over the past 2 decades. This diversity has an impact on cardiovascular disease presentation and outcomes. Within Africa and within the individual countries, one can find regions having predominantly communicable diseases such as rheumatic heart disease, tuberculous pericarditis, or cardiomyopathy and others having a marked increase in noncommunicable disease such as hypertension and hypertensive heart disease. Ischemic heart disease remains rare in most countries. Difficulties in the planning and implementation of effective health care in most African countries are compounded by a paucity of studies and a low rate of investment in research and data acquisition. The fiduciary responsibilities of companies working in Africa should include the effective and efficient use of natural resources to promote the overall health of populations.
C ardiovascular diseases (CVDs) with infectious and nutritional origins have long been the principal forms of heart disease in Africa. In this article, we use the term CVD resulting from communicable causes for rheumatic heart disease, HIV, virus-induced cardiomyopathy, etc. For CVD resulting from noncommunicable causes, for example, hypertension, cardiomyopathy, and myocardial infarction, we use the term CVD resulting from noncommunicable causes.
The epidemiological transition with a subsequent increase in hypertension and diabetes mellitus has seen an increased prevalence of noncommunicable forms of heart disease in most African populations. 1 This phenomenon is driven largely by population-wide changes in demographic, social, and economic status, with associated changes in lifestyle habits. [2] [3] [4] Nonetheless, the incidence of communicable CVD is sustained and fueled by the epidemics of the HIV/AIDS, rheumatic heart disease, tuberculosis, and parasitic infections with cardiac involvement. [5] [6] [7] In parallel, the rapid and marked increase in the prevalence of cardiovascular risk factors raises the spectrum of a potential epidemic of noncommunicable CVDs in an environment characterized by limited resources and infrastructure to combat these threats.
The aim of this thematic review is to describe the current knowledge of the impact of socioeconomic status and its relationship with risk factor profiles on CVD and regional epidemiology within Africa. Furthermore, we aim to review current and novel strategies for disease prevention, treatment, and behavioral change, as well as the progress of policy development. This is within the context of the substantial gaps in available data and its profound limitations. For many countries, we have either no data or only data collected within certain urban areas and certain population groups. In this article, we have summarized the gaps in knowledge and resources and our recommendations for the way forward, which we hope will assist in future healthcare planning.
Statistical Capacities for Gross Domestic Product Assessment in African Economies and Its Impact on Disease
The economic classification of countries has traditionally been based on the gross domestic product (GDP). The International Monetary Fund recommends that the base year for GDP estimation should be updated every 5 years. However, as Jerven 8, 9 highlighted in his recent perspective article and book, only a few countries in Africa are able to fulfill that standard; for most countries, the base years are about a decade or older. These significant errors are highlighted by recent examples of Ghana and Nigeria. Ghana's GDP was recalculated on the basis of a change in statistical methodology, and the country's GDP was revised upward to such an extent that Ghana's recorded GDP per capita almost doubled, leading to a reclassification from a low-income 1200 Circulation
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country to a lower-middle-income country. This dramatic jump was based on changing the base year from 1993 to 2006. 8 For Nigeria, the most populous nation on the African continent, the base year is 1990, and a revision is underway. Nigeria's economy is ≈50 times the size of that of an African country with one of the lowest economies, for example, Malawi. Doubling the estimates of the size of Nigeria's economy would have an enormous impact on any economic assessment of the continent. The poor quality of the current data makes any factual statement of the current aggregate trends of growth and poverty and subsequent continentwide estimates uncertain, thus complicating the prediction of healthcare consequences for individual African countries. GDP numbers and other statistics such as health statistics, which we often treat as fact, bear with them the caveat that these are often simply numbers or estimations produced under the most difficult circumstances. In particular, we have a paucity of knowledge of those who are the poorest or live in the most remote regions in Africa, as is the case among many indigenous populations. To change that situation, we would need recognition of the importance of data collection, substantial funding, and human resources. For most African countries, a typical Living Standard Measurement Survey, as developed by the Development Research Group of the World Bank, to improve the type and quality of household data collection by statistical offices in developing countries would be desirable. An e-learning course is available on their Web site (www.econ.worldbank.org). At present, most African countries do not have a specific budgetary allocation for that purpose because of either a lack of resources or a lack of a perceived need for such surveys.
Africa: A Continent Characterized by a Marked Ethnic, Sociodemographic, and Economic Diversity: Impact on CVD Presentation and Outcomes
Beside health surveys, a broad range of parameters are needed to assess the impact of economic development on cardiovascular and other manifestations of disease on different African populations. The African continent is highly diverse ethnically. This is reflected in Figure 1 , which exhibits color-coded regions of the African continent representing the 4 phyla of African language families consisting of an estimated 2000 languages. 10 Mother language defines ethnic groups and, to some extent, behavior based on traditions. Current political borders arise to a large extent from the colonial era and thus are not necessarily representative of the specific African ethnicities.
Africa has a large number of countries in the highest income inequality tertiles (Table 1) . 11 The Gini index or Gini This heterogeneity in different ethnic groups within a country is highlighted in the INTERHEART Africa study, 13, 14 reporting on the impact of education and income on risk factors for acute myocardial infarction among different ethnic groups living in South Africa.
A standardized case-control study of myocardial infarction, from which a total of 578 cases and 789 controls were recruited in the African continent (52 countries), was the basis of the INTERHEART Africa Study. In the black population, those who had <8 years of schooling as opposed to those with higher education showed an increased risk of acute myocardial infarction (odds ratio, 1.86; 95% confidence interval, 1.06-3.25). In contrast, there was no difference observed in the colored African group (odds ratio, 0.71;95% confidence interval, 0.30-1.68). The direction of association was just the opposite for the European/other African groups. In these groups, those with tertiary education had a significantly lower risk (odds ratio, 0.30; 95% confidence interval, 0.15-0.58) compared with those who attended school for <8 years. Probability values for the interaction of education and ethnicity and for the income-ethnicity interaction are <0.0001 ( Figure 2) .
The country-level risk factor estimates for 199 countries from a systematic analysis of population-based data by Danaei and colleagues 4 were used to analyze the trend in associations between per capita GDP and cardiovascular risk factors. A worldwide network of clinical and public health researchers and practitioners, the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group, has identified a unique data set on 5 risk factors: body mass index (BMI), blood pressure, serum cholesterol, fasting plasma glucose, and diabetes mellitus.
In 1980, 3 major metabolic risk factors for CVD, namely systolic blood pressure (SBP), total cholesterol, and BMI, were positively associated with income per country and Western diet at the national level. Re-evaluation of these factors in 
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2008 demonstrated that only serum cholesterol levels retained a strong positive association with national income. Data from the World Health Statistics for the African continent are subject to considerable uncertainty. They provide estimates that are based on data from multiple source, with limited availability and quality as a result of the inherent weaknesses in the statistical and health information systems in many African countries. The 2012 World Health Statistics referring to Africa report the following:
• The median prevalence of raised fasting blood glucose (ie, fasting glucose ≥126 mg/dL [7.0 mmol/L] or taking medication for raised blood glucose) among adults ≥25 years of age was 9.9% for men and 9.5% for women.
• The median prevalence of raised blood pressure (ie, SBP ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg) among adults ≥25 years of age was 34.6% for men and 28.3% for women.
• The median prevalence of obesity (ie, BMI ≥30 kg/m 2 ) among adults ≥20 years of age was 14.9% for men and 22.1% for women.
These reported figures are age-standardized point estimates that are adjusted for uncertainty ranges (available on the Global Health Observatory Web site, http://www.who.int/ gho).
In regard to the estimated prevalence of diabetes mellitus, there was relatively little variation across income groups and in different countries. This ranged from 8% in both sexes in low-income countries to 10% in high-middle-income countries. (http://www.who.int/nmh/publications/ncd_report2010)
The authors concluded that the changing associations between metabolic risk factors and macroeconomic variables suggested an upcoming global pandemic of hyperglycemia and diabetes mellitus, together with high blood pressure, in low-income countries regardless of income. 4 
Africa Cross-Country Associations of CVDs and Risk Factors Interlinked With GDP and Income Inequality
A recent series of publications in The Lancet [15] [16] [17] [18] reported national, regional, and global trends in the prevalence of BMI, serum cholesterol, plasma glucose, and SBP since 1980 in 199 countries and territories, including data from >5 million participants.
Obesity prevalence in men and women varied fundamentally within Africa ( Figure 3A) , with the prevalence of overweight and obese women being highest in southern Africa in 2008 and still remarkably low in West, East, and Central Africa. The prevalence rate of obesity in African men is in general lower than that in women. 15 Serum total cholesterol in 2008 was lowest in Sub-Saharan Africa at 4.08 mmol/L (3.82-4.34 mmol/L) for men, and 4.27 mmol/L (3.99-4.56 mmol/L) for women and highest in Cameroon, Namibia, Botswana, and Tanzania, according to the World Health Organization (WHO) Infobase in 2010. 16 Mean fasting plasma glucose in 2008 was also lowest in Sub-Saharan Africa. However, investigating the change in country age-standardized SBP between 1980 and 2008 demonstrated a rise in SBP in East Africa for both sexes and in West Africa for women, with the increase ranging from 0.8 to 1.6 mm Hg per decade in men and 1.0 to 2.7 mm Hg per decade in women. According to the WHO country-specific data on the mean prevalence rates of hypertension among adult men and women, the mean prevalence rates of hypertension in West (ie, 43% versus 40%) and East (ie, 40% versus 37%) African men are higher than those in women, whereas those in southern African males (ie, 34% versus 40%) are lower than in females. The mean prevalence rates of hypertension are equal among adult northern African men and women (ie, 39% versus 38%).
However, the authors of the articles by the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group clearly highlight that the main limitation of their studies is that despite extensive attempts at data collection, many countries do not have specific data, especially for the 1980s. 15 The absence of those data is reflected in wider uncertainty intervals. In total, SBP is currently highest in low-and middle-income countries worldwide, including many African countries.
Studies have identified economic development, as measured by the GDP per capita, as a predictor of CVD risk factors. In a cross-national analysis of 85 countries, Ezzati et al 23 observed a concave and nonlinear association between GDP per capita, mean BMI, and serum cholesterol, with higher risk factor levels at intermediate (versus low) GDP levels and comparable to slightly lower risk factor levels at high (versus intermediate) GDP levels. Data were not specifically analyzed per region, for example, Africa.
Kim et al 11 reported cross-country associations of income inequality with CVD and risk factors. They collected a large set of data from 78 countries, within which 14 of the 26 countries in the highest inequality tertile defined by the Gini coefficient were located on the African continent (Table 1) . 11 Income inequality is likely to have an effect on cardiovascular risk factors, the epidemiological transition within the different African countries, and the many ethnic groups living in rural and urban areas.
Pampel et al 24 and Goyal et al 25 described that although socioeconomic status and weight have a positive association in low-income countries, they have a negative association in higher-income countries. However, the authors introduce a caveat emphasizing that the relationship and its causes need to be tested in large and diverse national databases. Figure 3A through 3D shows the prevalence of cardiovascular risk factors such as obesity, hypertension, cholesterol, cigarette/tobacco smoking, and diabetes mellitus within the different regions of Africa as published from the WHO InfoBase, International Federation of Diabetes, and World Bank. It is challenging to find data on the minimum legal ages of smoking and, more important, the implementation and compliance with specific laws and regulations to address the worsening epidemic of tobacco and tobacco-associated illnesses in various African countries. Many African countries have not complied fully with the Framework Convention on Tobacco Control. The Framework Convention on Tobacco Control legislates protection from tobacco smoke exposure; the packaging and labeling of tobacco products; and the advertising, promotion, and sponsorship of tobacco products. Pampel 27 examined data on tobacco use among men (age, 15-54 years) and women (age, 15-49 years) from 16 demographic health surveys in 14 Sub-Saharan countries. According to Pampel's analysis, the gradation of the prevalence of cigarette smoking increases from among West-Central African men (lowest use) to southern African men (medium use) and then to men from Madagascar and East-Central Africa (highest use). The highest prevalence of cigarette smoking was observed among urban, less educated men and women of lower socioeconomic status, although the prevalence rates of women cigarette smokers were lower than the rates for their male counterparts.
The observed region-specific risk factors are quite complex to explain, and associations between region-specific variables and the prevalence rates of the cardiovascular risk factors may not have been definitively measured as a result of financial and infrastructural difficulties in designing studies to capture such data. However, in general, southern Africa (particularly South Africa), and northwest Africa, for example, Algeria, have the highest percentages of obesity, undiagnosed diabetes mellitus, smoking, and high cholesterol. SBP levels are generally high but particularly high in western and eastern Africa. However, some of the findings are puzzling, for example, the fact that the estimated mean cholesterol for the populations of Namibia and Botswana is >4.6 mmol/L ( Figure 3C ) and among the highest on the continent. Both countries have a particularly high proportion of people still living a rural lifestyle, for example, the Himba and Ovambo in northern Namibia and the Khoi-San in northern South Africa, Botswana, and Namibia. Many are herders and migrants. It is very unlikely that people belonging to these ethnic groups have high cholesterol. The findings used in this WHO global comparable estimate are probably based on findings from urban populations and small studies. Mensah 3 provided a descriptive epidemiology of cardiovascular risk factors and diabetes mellitus in Sub-Saharan Africa. Rising BMI, particularly in women from southern Africa, and high blood pressure in East Africa for both sexes and in West Africa for women were the most important cardiovascular risk factors.
Research and Development in Africa and Impact on CVD Research and Management
There is a link between investment in research and macroeconomic growth in that the fraction of GDP that countries spend on research and development (R&D) is highly correlated with the fraction of their population who are scientists and engineers. 28 Technology, although not exactly a form of capital, is related to human and intellectual capital and is capable of generating positive feedback, which enables a virtuous cycle of exponential growth. 29 To the classic factors of production that affect exponential economic growth, we might add various forms of human capital such as investment in education and intellectual property. 28 It would appear that nations who spend close to 3% of their GDP on R&D are usually more successful when competing for economic growth opportunities than those who spend less. 28 By world standards, despite having risen in most Only about 0.3% of GDP of the continent is devoted to R&D, which is 7 times less than that spent by industrialized countries on this sector. Although recent economic data show that Nigeria's economy has overtaken South Africa's to become the continent's largest and the world's 26th most productive, South Africa spends more on R&D. With its investment rising from 0.73% in 2001 to 0.97% in 2007 as a proportion of GDP, South Africa is the only country in the continent that comes close to the 1% mark for the R&D expenditure and leads in terms of scientific publications, with 46% of the continent's entire share, far ahead of Nigeria (11.4%). 30 Major challenge for R&D in Africa are the low literacy rate, poor quality of education, and brain drain. At least one third of all African researchers or those with engineering degrees were living and working in developed countries in 2009. Several African countries (eg, Uganda, Cameroon, Botswana) are striving to address this problem by increasing academic' salaries, as well as offering other incentives. 30 Nonetheless, to reach the suggested target of 1000 researchers per 1 million population by 2025, radical changes will need to be implemented. 30 A fundamental issue, which will take time, vision, and a fundamental commitment from governments to be overcome, is the overall lack of resources and competing demands for the treatment and prevention of both communicable and noncommunicable diseases. It is imperative that the R&D objectives be specifically focused and tailored toward those disease entities that are highly prevalent on the African continent and on issues and obstacles in regard to documenting their epidemiology, treatment, and prevention.
The poor state of R&D in Africa, which explains in part the lack of population-wide data, has important implications for research on CVD prevalence, risk factors, and outcomes. The shortage of trained physicians and cardiologists, inadequate specialized cardiac facilities and equipment, and low levels of education, as well as lack of patient and public awareness, may lead to among patients lead many patients not having access to basic diagnostic facilities such as electrocardiography and echocardiography, medical therapies (eg, streptokinase, β-blockers), and advanced cardiac care. In addition, many regions have no access to any form of device treatment (eg, pacemaker insertion). The management of the communicable forms of CVD such as rheumatic heart disease, tuberculous pericarditis, and endomyocardial fibrosis (still the most common forms of CVD in many African countries) remains suboptimal because of a lack of screening facilities such as echocardiography and access to cardiothoracic surgery. 31 Standard guidelines, for example, for acute and chronic heart failure, are subsequently not implemented, leading to poor patient outcome. Recently, the Pan-African Cardiac Society has been taking a more active role in context-appropriate guideline development and implementation. 32 This society has representation from southern, eastern, western, and northern Africa and formed recently dedicated working groups to address the large burden of hypertension and heart failure on the continent.
Implications for Clinical and Public Health Action
In an article published in The Lancet under the theme of Global Governance for Health, Ottersen and colleagues 33 highlighted that the unacceptable health inequities within and between countries globally and in Africa cannot be addressed within the health sector alone but require global political solutions. Improved global health in return increases trade, stability, and prosperity, and it would be in the self-interest of the higher-income countries to facilitate this process, in addition to the moral imperative. 34 From a local and regional standpoint, however, it must be appreciated that the control of many of the risk factors will require social and economic engineering, as well as the involvement and will of the legislative branch. Such multidimensional approaches are essential to tackle the important factors such as second hand smoking, air pollution, provision of space, and facilities for exercise and school sporting activities. The Republic of the Seychelles, a rapidly developing small island state located east to Kenya, is a good example that this can be achieved by targeted action. Between 1989 and 2010, age-standardized stroke and myocardial infarction mortality decreased markedly which has been attributed to improved control of persons with high blood pressure and diabetes mellitus over time as well as increasing leisure time physical activity. 35 This is remarkable because costly invasive procedures such as percutaneous coronary intervention and fibrinolysis are used only rarely in the Seychelles. Hence, the lessons to be learned from the Seychelles are that collection of goodquality data on cause-specific mortality and implementation of good clinical practice such as blood pressure control can lead to a reduction in morbidity and mortality. 36 It would be of particular importance to get the cooperation of industry and food manufacturers to limit the advertising of unhealthy food choices, alcohol, and tobacco. In South Africa, a large food store has introduced a discount for low-glycemicindex breads, fruit, and vegetables, thus incentivizing healthy food choices. Several medical aid providers offer a discount on monthly fees if weight loss has been achieved, sports clubs are visited several times a week, and screening for CVD is followed by a certain age group. Figure 4 37 summarizes the possible contributing factors to the epidemic of noncommunicable diseases that can be seen in many urban and rural parts of Africa and re-emphasizes that only a concerted effort from government, industry, and the health sector on both a global and a regional basis will stand a chance of telescoping the epidemiological transition and the epidemic of CVD in lowand middle-income countries, including the African continent. Table 2 summarizes our recommendations based on the WHO "Best Buys" approach. It lists the gaps in knowledge and barriers to adequate management of noncommunicable diseases in a continent where health professionals' training and healthcare systems are designed to prevent and manage endemic communicable diseases such as malaria, tuberculosis, and HIV/AIDS. Because of the limited resources and lack of infrastructure for the diagnosis and management of noncommunicable diseases at the primary level, we suggest possible strategies toward strengthening health systems, focusing on 4 major areas: (1) the development of human resources, (2) an improvement in infrastructure for diagnosis and management of noncommunicable diseases at the primary level, (3) implementation of basic registries for mapping of noncommunicable diseases and risk factors in different populations and age groups, and (4) the establishment of partnerships with stakeholders outside the health sector.
Mapping of the pattern of noncommunicable diseases will be needed to allow health policy makers to increase access to diagnostic tools and low-cost generic primary prevention medications. Innovative strategies will be needed, building on current strategies on task shifting or task sharing in Rwanda 38 and Mozambique, 39, 40 the results of which are encouraging. Although thought to further exacerbate income and healthcare inequality, industry involvement in promoting high-tech imaging, devices, and procedures may be revolutionary. If cost-effective strategies are chosen, directed to the relevant problems and tailored to the local conditions, hightech tools may be developed both to assess the epidemiology and to improve the management of noncommunicable diseases in low-resource areas. 38 In line with this, African leadership has moved from skepticism to investment in portable and battery-powered laboratory devices, training of nonspecialists on the use of diagnostic tools and provision of care, and promotion of the use of multiplex rapid test systems at point of care for the assessment of cardiovascular risk factors.
Finally, partnerships with the other players in the government are essential, for example, interventions and legislation for the promotion of healthy food, healthy working environment and physical activity at workplace.
Conclusions
We have provided evidence that Africa is a continent characterized by marked ethnic, sociodemographic, and economic diversity. Profound changes have occurred in many regions over the past 2 decades that have had an impact on CVD presentation and outcomes. Within Africa and the individual countries, one can find regions affected predominantly by communicable diseases. Concomitantly, there is an increase in the number of areas affected by a marked increase in obesity, diabetes mellitus, smoking, and cholesterol. These factors lead to a double burden of communicable and noncommunicable disease on the continent.
Poor data and low investment in R&D in almost all African countries have resulted in very limited data on CVDs and risk factors for most countries, which complicates effective healthcare planning. Therefore, strengthening of health system and investment in surveys to describe the pattern of noncommunicable diseases in the continent are mandatory. Collaborative programs involving the communities, the industry, and partnerships from other sectors of the government would likely lead to better overall use of resources and result in national and continental growth. 
